Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
17.39
-0.26 (-1.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Anika Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 255 | 332 | 432 | 517 | 643 | 740 | Upgrade
|
| Market Cap Growth | 34.08% | -23.28% | -16.40% | -19.60% | -13.05% | 54.90% | Upgrade
|
| Enterprise Value | 220 | 290 | 376 | 447 | 567 | 589 | Upgrade
|
| Last Close Price | 17.39 | 22.66 | 29.60 | 35.83 | 45.26 | 51.85 | Upgrade
|
| PE Ratio | - | - | - | 125.13 | - | 27.21 | Upgrade
|
| Forward PE | 41.40 | - | - | - | 62.00 | 31.36 | Upgrade
|
| PS Ratio | 1.56 | 1.99 | 2.77 | 3.50 | 4.93 | 6.46 | Upgrade
|
| PB Ratio | 1.42 | 1.56 | 1.51 | 1.80 | 2.36 | 2.57 | Upgrade
|
| P/TBV Ratio | 2.16 | 1.66 | 2.12 | 2.63 | 3.72 | 2.71 | Upgrade
|
| P/FCF Ratio | - | - | - | 158.96 | 56.25 | 21.65 | Upgrade
|
| P/OCF Ratio | 34.14 | - | 98.08 | 61.60 | 49.24 | 19.99 | Upgrade
|
| PEG Ratio | 2.07 | - | - | 161.40 | 3.10 | 2.51 | Upgrade
|
| EV/Sales Ratio | 1.34 | 1.74 | 2.41 | 3.03 | 4.34 | 5.14 | Upgrade
|
| EV/EBITDA Ratio | - | 115.43 | - | 194.38 | 151.74 | 14.51 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 17.02 | Upgrade
|
| EV/FCF Ratio | - | - | - | 137.51 | 49.55 | 17.24 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.14 | 0.11 | 0.07 | 0.08 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | - | 4.64 | 19.86 | 4.12 | 3.52 | 0.52 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 6.44 | 1.96 | 0.66 | Upgrade
|
| Asset Turnover | 0.59 | 0.54 | 0.45 | 0.41 | 0.37 | 0.38 | Upgrade
|
| Inventory Turnover | 2.01 | 1.46 | 1.57 | 1.42 | 1.80 | 1.33 | Upgrade
|
| Quick Ratio | 3.56 | 3.50 | 4.33 | 4.17 | 3.32 | 12.78 | Upgrade
|
| Current Ratio | 5.34 | 5.26 | 6.07 | 5.66 | 4.81 | 14.39 | Upgrade
|
| Return on Equity (ROE) | -43.31% | -33.21% | -5.19% | 1.48% | -8.55% | 9.85% | Upgrade
|
| Return on Assets (ROA) | -4.01% | -2.36% | -2.91% | -2.11% | -1.75% | 7.10% | Upgrade
|
| Return on Capital (ROIC) | -4.42% | -2.62% | -3.24% | -2.49% | -2.01% | 7.54% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | - | - | - | 11.02% | Upgrade
|
| Earnings Yield | -38.29% | -24.92% | -3.44% | 0.80% | -3.73% | 3.68% | Upgrade
|
| FCF Yield | -0.32% | -2.17% | -0.71% | 0.63% | 1.78% | 4.62% | Upgrade
|
| Buyback Yield / Dilution | -0.61% | -0.65% | 0.50% | -2.90% | 1.06% | 2.14% | Upgrade
|
| Total Shareholder Return | -0.61% | -0.65% | 0.50% | -2.90% | 1.06% | 2.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.